Incyte Corporation vs J B Hunt Transport Services Inc — how do they compare? Incyte Corporation trades at $115.7 (market cap $23.11B), while J B Hunt Transport Services Inc trades at $292.56 (market cap $27.36B). The key difference: J B Hunt Transport Services Inc is the larger of the two by market cap, and J B Hunt Transport Services Inc pays a 0.62% dividend while Incyte Corporation pays none. Which is the better fit depends on your goals.
| INCY | JBHT | |
|---|---|---|
Market Cap | $23.11B | $27.36B |
Sector | Health | Industrials |
52-Week High | $118.52 | $298.41 |
52-Week Low | $67.38 | $130.65 |
Enterprise Value | $19.13B | $28.50B |
Dividend Yield | — | 0.62% |
Trailing returns across standard periods
Latest headlines on both assets
Incyte focuses on the discovery and development of small-molecule drugs. The firm's lead drug, Jakafi, treats two types of rare blood cancer and graft versus host disease and is partnered with Novartis. Incyte's other marketed drugs include rheumatoid arthritis treatment Olumiant (licensed to Lilly), and oncology drugs Iclusig (chronic myeloid leukemia), Pemazyre (cholangiocarcinoma), Tabrecta (lung cancer), and Monjuvi (diffuse large B-cell lymphoma). The firm's first dermatology product, Opzelura, was approved in 2021 for atopic dermatitis. Incyte's pipeline includes a broad array of oncology and dermatology programs.
Read more on INCY →J.B. Hunt Transport Services ranks among the top surface transportation companies in North America by revenue. Its primary operating segments are intermodal delivery, which uses the Class I rail carriers for the underlying line-haul movement of its owned containers (45% of sales in 2021).
Read more on JBHT →